Activating Transcription Factor 5 (ATF5) (C-Term) Peptide
Quick Overview for Activating Transcription Factor 5 (ATF5) (C-Term) Peptide (ABIN973557)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- EGEALEGECQ GLEARNRELR ERAESVEREI QYVKDLLIEV YKARSQRTRS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Atf5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ATF5 (Activating Transcription Factor 5 (ATF5))
-
Background
-
Atf5 plays a role in inhibition of nerve growth factor-induced neuronal outgrowth and regulation of neurogenesis.
Alias Symbols: -
Protein Size: 281 -
Molecular Weight
- 30 kDa
-
Gene ID
- 282840
-
NCBI Accession
- NM_172336, NP_758839
-
UniProt
- Q6P788
Target
-